Lipocine Inc. (LPCN)

Lipocine Revenue

Lipocine had revenue of $4.71M in the twelve months ending March 31, 2024, with 748.91% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.62M with 13,751.93% year-over-year growth. In the year 2023, Lipocine had annual revenue of $-2.85M, a decrease of -670.16%.

• Revenue (ttm): $4.71M
• Revenue Growth: +748.91%
• P/S Ratio: 8.58
• Revenue / Employee: $277,139
• Employees: 17
• Market Cap: 40.43M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-2.85M	-3.35M	-670.16%
Dec 31, 2022	500.00K	-15.64M	-96.90%
Dec 31, 2021	16.14M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	164.99K	-263.04K	-61.45%
Dec 31, 2018	428.03K	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	7.71M	-	-
Dec 31, 2011	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.